Antiplatelet and anticoagulant drugs do not affect visual acuity in the comparing bevacizumab to ranibizumab in age-related macular degeneration (BRAMD) trial

被引：0
|
作者：
Schauwvlieghe, A. M. E. [1 ]
Buitendijk, G. H. S. [1 ]
Dijkman, G. [1 ]
Hoyng, C. [1 ]
Hooymans, J. M. [1 ]
Verbraak, F. D. [1 ]
Vingerling, J. R. [1 ]
Claver, C. C. [1 ]
Schlingemann, R. O. [1 ]
机构：
[1] Acad Med Ctr, Amsterdam, Netherlands
来源：
ACTA OPHTHALMOLOGICA | 2017年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：22 / 23
页数：2
相关论文
共 50 条
  • [31] OUTCOME OF BEVACIZUMAB (AVASTIN) INJECTION IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION AND LOW VISUAL ACUITY
    Ehrlich, Rita
    Weinberger, Dov
    Priel, Ethan
    Axer-Siegel, Ruth
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (09): : 1302 - 1307
  • [32] INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Effect of Baseline Visual Acuity
    El-Mollayess, Georges M.
    Mahfoud, Ziyad
    Schakal, Alexandre R.
    Salti, Haytham I.
    Jaafar, Dalida
    Bashshur, Ziad F.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2013, 33 (09): : 1828 - 1835
  • [33] Intravitreal Bevacizumab Injection in Patients With Neovascular Age-Related Macular Degeneration and Low Visual Acuity
    El Matri, L.
    Bouraoui, R.
    Landolsi, H.
    Kort, F.
    Chebil, A.
    Limaiem, R.
    Mghaieth, F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [34] RISK FOR LOW VISUAL ACUITY AFTER 1 AND 2 YEARS OF TREATMENT WITH RANIBIZUMAB OR BEVACIZUMAB FOR PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Westborg, Inger
    Albrecht, Susanne
    Rosso, Aldana
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (11): : 2035 - 2046
  • [35] The Use of Ranibizumab in Age Related Macular Degeneration Patients With Low Visual Acuity
    Niskopoulou, M.
    Kotsolis, A.
    Massaoutis, P.
    Mpaltatzis, S.
    Ladas, I. D.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [36] Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials
    Waldstein, Sebastian M.
    Simader, Christian
    Staurenghi, Giovanni
    Chong, N. Victor
    Mitchell, Paul
    Jaffe, Glenn J.
    Lu, Chengxing
    Katz, Todd A.
    Schmidt-Erfurth, Ursula
    OPHTHALMOLOGY, 2016, 123 (07) : 1521 - 1529
  • [37] Evaluation of Injection Frequency and Visual Acuity Outcomes for Ranibizumab Monotherapy in Exudative Age-related Macular Degeneration
    Dadgostar, Hajir
    Ventura, Alexandre A. C. M.
    Chung, Jeffrey Y.
    Sharma, Sumit
    Kaiser, Peter K.
    OPHTHALMOLOGY, 2009, 116 (09) : 1740 - 1747
  • [38] Functional visual acuity in patients with age-related macular degeneration
    Iida, Masaharu
    Okamoto, Yoshifumi
    Hoshi, Sujin
    Okamoto, Fumiki
    Hiraoka, Takahiro
    Oshika, Tetsuro
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [39] Driving and Visual Acuity in Patients with Age-Related Macular Degeneration
    Patnaik, Jennifer L.
    Pecen, Paula E.
    Hanson, Kara
    Lynch, Anne M.
    Cathcart, Jennifer N.
    Siringo, Frank S.
    Mathias, Marc T.
    Mandava, Naresh
    OPHTHALMOLOGY RETINA, 2019, 3 (04): : 336 - 342
  • [40] The effects of ranibizumab injections on fluorescein angiographic findings and visual acuity recovery in age-related macular degeneration
    Gungel, Hulya
    Osmanbasoglu, Ozen Ayranci
    Altan, Cigdem
    Baylancicek, Deniz Oygar
    Pasaoglu, Isil Basgil
    CLINICAL OPHTHALMOLOGY, 2014, 8 : 981 - 988
12345